Long-chain and very long-chain ceramide levels in subjects with impaired glucose regulation
Open Access
- 2 July 2025
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (5) , 1408-1415
Abstract
No abstract availableKeywords
Funding Information
- European Union's Research and Innovation
- Medical University Sofia (D-140/24.06.2020)
- Medical University Sofia (-140/24.06.2020)
- European Commission
- EFSD
This publication has 36 references indexed in Scilit:
- Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney DiseaseKidney International Reports, 2017
- Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profileAtherosclerosis, 2017
- Pathophysiology of diabetic dyslipidaemia: where are we?Diabetologia, 2015
- C16:0-Ceramide Signals Insulin ResistanceCell Metabolism, 2014
- Ceramide synthases as potential targets for therapeutic intervention in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Ceramide and the mitochondrial respiratory chainBiochimie, 2014
- Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosisAtherosclerosis, 2009
- Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetesDiabetologia, 2007
- The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985